Margot Chima
Overview
Explore the profile of Margot Chima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renert-Yuval Y, Da Rosa J, Garcet S, Pavel A, Bares J, Chima M, et al.
Br J Dermatol
. 2022 Jun;
187(4):539-547.
PMID: 35656793
Background: Although alopecia areata (AA) greatly impacts patients' quality of life (QoL), there is no adequate validation of AA-targeted QoL surveys in clinical trials, hindering sufficient representation of patient-reported outcomes....
2.
Tham K, Lefferdink R, Duan K, Lim S, Wong X, Ibler E, et al.
Br J Dermatol
. 2022 May;
187(4):557-570.
PMID: 35633118
Background: The ichthyoses are rare genetic keratinizing disorders that share the characteristics of an impaired epidermal barrier and increased risk of microbial infections. Although ichthyotic diseases share a T helper...
3.
Babalola F, Chima M, Jobarteh R, Gottlieb A
J Drugs Dermatol
. 2022 Mar;
21(3):313-314.
PMID: 35254754
Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular...
4.
Lefferdink R, Rangel S, Chima M, Ibler E, Pavel A, Kim H, et al.
Arch Dermatol Res
. 2022 Feb;
315(2):305-315.
PMID: 35218370
Importance: Treatment of congenital ichthyoses primarily focuses on reversing skin scaling and is not pathogenesis based. Recent studies showed Th17 immune skewing, as in psoriasis, across the spectrum of ichthyosis,...
5.
Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, Hawkes J, Gilleaudeau P, et al.
Allergy
. 2021 Aug;
77(3):897-906.
PMID: 34460948
Background: Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited, and recent evidence supports a role for type 2 T-cell (Th2)-immune response in AA. Dupilumab, a...
6.
Leight-Dunn H, Chima M, Hoss E
J Drugs Dermatol
. 2020 Nov;
19(11):1050-1055.
PMID: 33196756
Laser resurfacing has progressed since the 1980s to treat a variety of medical and aesthetic indications with ever-evolving safety parameters. While laser technology has evolved to provide a more favorable...
7.
Ungar B, Pavel A, Li R, Kimmel G, Nia J, Hashim P, et al.
J Allergy Clin Immunol
. 2020 May;
147(1):394-397.
PMID: 32428528
No abstract available.
8.
Hashim P, Chima M, Kim H, Bares J, Yao C, Singer G, et al.
J Am Acad Dermatol
. 2019 Jul;
82(2):360-365.
PMID: 31279028
Background: Psoriasis of the intertriginous, anogenital, and facial regions remains a therapeutic challenge, with current algorithms lacking a topical agent that exhibits both high efficacy and minimal side effects. Objective:...
9.
Kimmel G, Chima M, Kim H, Bares J, Yao C, Singer G, et al.
J Am Acad Dermatol
. 2019 May;
81(3):857-859.
PMID: 31078609
No abstract available.
10.
Czarnowicki T, He H, Leonard A, Kim H, Kameyama N, Pavel A, et al.
J Allergy Clin Immunol
. 2018 Dec;
143(6):2095-2107.
PMID: 30576756
Background: Peripheral blood skin-homing/cutaneous lymphocyte antigen (CLA) T cells emerge as biomarkers of cutaneous immune activation in patients with inflammatory skin diseases (atopic dermatitis [AD] and alopecia areata [AA]). However,...